En
Ar
Osbone®
Osbone® is a synthetic open–cell cancellous bone graft material for filling bone defects and for augmentation of the atrophied alveolar ridge. This volume–stable product, which is slowly resorbed by bone, thus provides a perfect scaffolding for rapid and maximally stable bone regeneration.
Chemically it is a hydroxyapatite (chemical formula Ca5(PO4)3OH or, in double annotation, Ca10(PO4)6(OH)2). Compared to materials of biological origin, Osbone®, as a purely synthetic material, eliminates laborious treatment with alkali and heat for the removal of organic components. This underscores the safety aspect of this product.
- No residual risks of infections and allergic reactions
- Consistent product quality thanks to synthetic starting materials
- Ensures fast and long-term stability of the scaffolding for bone regeneration
- High material strength and slow resorption kinetics combined with an open, interconnecting porosity ensures complete healing and lasting volume stability over time
Filling or repair of multi–wall bone defects, such as:
- Defects following extirpation of bone cysts
- Augmentation of an atrophied alveolar ridge
- Sinus lift or sinus floor elevation (subantral augmentation)
- Filling of alveolar defects following tooth extraction for alveolar ridge preservation
- Filling of extraction defects for prepping an implant bed
- Filling of two or multi–wall infrabony pockets and bi– and trifurcation defects
- Support function for a membrane with guided tissue regeneration (GTR)
- Defects following surgical removal of impacted or retained teeth or corrective osteotomies
- Other multi–wall infrabony defects of the alveolar process and of the facial skull
Indications may differ from country to country
Hydroxyapatites have been used for decades as a bone substitute in the entire skeletal system. In principle, we differentiate between hydroxyapatites that were synthesized from the minerals calcium and phosphate and hydroxyapatites of allogenic or xenogenic origin.
In the case of materials of biological origin, a laborious treatment with alkali and heat is done to remove organic components.
Allogenic vs xenogenic hydroxyapatites
In the case of hydroxyapatites of human origin, expensive donor programs are required in order to ensure a safe source.
Groups of animals that are used for harvesting xenogenic hydroxyapatite must be kept isolated under strict guidelines. Although the safety standards are set very high in the production of the bone grafting material, a residual risk of transmitting infections cannot be eliminated completely. There is likewise a potential residual risk of immune reactions.
The synthetic alternative
Synthesized pharmaceuticals and medical devices can be manufactured in higher purity and thus comply with the standards of modern medicine. This has already gained acceptance in many areas. Because of the synthetic starting materials used in the production of Osbone® a long–lasting consistent quality has also been assured. The user can rely on using a material with consistent properties and quality.
Osbone® makes it possible for the clinician to provide simplified patient information. With Osbone®, explanations of the biological origin of the material, its source, and possible residual risks induced by the product for infections and immune reactions no longer need to be made.
With Osbone® you provide your patients with a safe and convincing alternative without a biological history.
Osbone® – Small
| Granule size | Volume | Item Number |
| 250-1000 µm | 5 x 0,25 cc | 9000 800 255 |
| 250-1000 µm | 1 x 0,5 cc | 9000 800 501 |
| 250-1000 µm | 5 x 0,5 cc | 9000 800 505 |
| 250-1000 µm | 1 x 1 cc | 9000 801 001 |
| 250-1000 µm | 5 x 1 cc | 9000 801 005 |
Osbone® – Large
| Granule size | Volume | Item Number |
| 1000-2000 µm | 1 x 1 cc | 9000 901 001 |
| 1000-2000 µm | 5 x 1 cc | 9000 901 005 |
| 1000-2000 µm | 1 x 2 cc | 9000 902 001 |